Carlsmed Names Richard Heppenstall CFO; Company Reiterates Fiscal 2026 Revenue Guidance

09:24 AM EDT, 09/28/2026 (MT Newswires) -- Carlsmed (CARL) said Monday that Richard Heppenstall has been appointed chief financial officer, effective immediately. Heppenstall succeeds Leo Greenstein, who has been CFO since 2023 and is leaving Carlsmed, the medical technology company said. Heppenstall was previously CFO of ZimVie from September 2021 until the company was acquired by ArchiMed in October, Carlsmed said. Carlsmed said it is reaffirming its fiscal 2026 revenue guidance of $74 million to $78 million. Analysts polled by FactSet are looking for $76.7 million.